AL
ALNY
-0.9%🟢 Fundamentally supportedAlnylam Pharmaceuticals, Inc. · Healthcare
$231.83Vol 1.40M · 1.1× normalMkt cap −$0.29BMarket closed — 2026-10-16 session
What happened
Move
-0.9%
Price
$231.83
Volume
1.40M
1.1× normal
Market cap
$31.02B
−$0.29B today
Why it moved
Guidance loweredmedium confidence
- Alnylam Pharmaceuticals (ALNY) vs. IONS and ARWR: Can Pipeline Growth Restore Confidence After the Guidance Cut? — finnhub-news
- Citigroup Maintains Buy on Alnylam Pharmaceuticals, Lowers Price Target to $320 — finnhub-news
Possible catalyst: guidance lowered.
Verdict — was the move justified?
🟢 Fundamentally supported
Guidance lowered — direction and rough magnitude are consistent with the identified fundamental catalyst.
How unusual is this move
σ score
0.3σ
vs own 20d volatility
Percentile
36th
of 1278 daily moves
Avg daily move
±1.9%
own 5y average
Fundamental context
V 52G 50P 65H 50Q 57
Insider activity (90d): net selling $398.9K
Valuation context
P/E (TTM)
38.4
5y median 78.4
P/E percentile
9%
vs own 1y history
FCF yield
0.0%
Trading cheaper than 91% of its own historical valuation range.
Full fundamental analysis on PreMarketPrice
Pillar scores, financial statements, valuation history, news & more for ALNY